Showing results (211-220 of 782) with videos related to
Sort By:
Pageof 79
Biochemistry|September 20, 1994
A novel mutant topoisomerase II alpha present in VP-16-resistant human melanoma cell lines has a deletion of alanine 429J A Campain, M M Gottesman, I PastanAnnals of Hematology|October 1, 1994
P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cellsT Licht, I Pastan, M Gottesman, et al.Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|August 1, 1991
Multidrug resistant transgenic mice as a novel pharmacologic toolG H Mickisch, I Pastan, M M GottesmanFEBS Letters|October 6, 1986
Reduction of EGF receptor synthesis by antisense RNA vectorsJ Hunts, G Merlino, I Pastan, et al.Proceedings of the National Academy of Sciences of the United States of America|June 1, 1970
Cyclic AMP receptor protein of E. coli: its role in the synthesis of inducible enzymesM Emmer, B deCrombrugghe, I Pastan, et al.Proceedings of the National Academy of Sciences of the United States of America|October 1, 1974
Myosin is a component of the cell surface of cultured cellsM C Willingham, R E Ostlund, I PastanProceedings of the National Academy of Sciences of the United States of America|April 1, 1973
Transformation of chick-embryo fibroblasts by wild-type and temperature-sensitive Rous sarcoma virus alters adenylate cyclase activityW B Anderson, G S Johnson, I PastanThe Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|May 1, 1980
Ultrastructural localization of tubulin in cultured fibroblastsM C Willingham, S S Yamada, I PastanHuman Gene Therapy|March 21, 2000
Chemoprotection of hematopoietic cells by a mutant P-glycoprotein resistant to a potent chemosensitizer of multidrug-resistant cancersP Hafkemeyer, T Licht, I Pastan, et al.Annals of Hematology|April 1, 1996
The multidrug-resistance gene in gene therapy of cancer and hematopoietic disordersT Licht, I Pastan, M M Gottesman, et al.Pageof 79